Executive Board

  • Yann GODFRIN, Ph.D.

    Chief Executive Officer

    15+ years of experience in management of biopharmaceutical companies focused product development. Co-founder, former CEO and CSO of ERYTECH Pharma, former CEO of Hemoxymed Europe, Dr Godfrin is an expert in pre-clinical and clinical product development strategy and has been consultant for several biotech companies. He is the inventor of more than 15 patents families and several scientific publications. Dr Godfrin holds a Ph.D. degree in Health & Life Sciences from the University of Nantes, an Engineer degree in Biomedical Sciences from the University of Compiegne and a Master degree in Pharmaceutical Drug Development from the University of Lyon.

 

Supervisory Board

The supervisory board is non-executive, advise and control the executive board of the company.

  • Pierre-Olivier GOINEAU, Ph.D.

    President of the Supervisory Board

    +20 years of experience in business development, especially in biotech/biopharma area. Co-founder and former CEO of Erytech Pharma, Mr Goineau is former President of the association France Biotech, and is currently member of several supervisory boards.

  • François MICELI

    Member

    Representative of Sofimac Partners

    +25 years of experience as entrepreneur and in risk capital investment in biotech companies. François is graduated in biological engineering from UPEC Paris XII, in corporate finance at INSEAD and was an auditor at the IHDEN.

    He is Senior Partner in the Technological Team and Member of the Management Board of Sofimac Partners.

  • Philippe Du MESNIL

    Member

    Representative of Fa Dièse,

    Philippe Du MESNIL is former CEO at CEVA Santé Animale.

  • Luca BOLLIGER, Ph.D.

    Independant member

    20+ years of experience in the pharmaceutical industry. First as Global discovery portfolio manager at Hoffmann-La Roche Ltd. He then pursued his career in the financial industry as a Fundamental analyst at BT&T asset management. He established Biopolo Ticino before becoming Director Business Development at Actelion. Luca Bolliger joined Recordati from Novimmune where he is VP and Director Corporate Licensing.

  • Foucauld DE TINGUY DU POUET

    Independant member

    Foucauld de Tinguy du Pouet (HEC), founded a bank specialized in financial enginnering and in  bond and share arbitrage. He later was executive director of the largest independent French financial analysis company.